{"organizations": [], "uuid": "83ba8719ad3b4c4fd73765c57278e4bb3805a457", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/07/the-associated-press-nevro-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Nevro: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-08T00:39:00.000+03:00", "replies_count": 0, "uuid": "83ba8719ad3b4c4fd73765c57278e4bb3805a457"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/07/the-associated-press-nevro-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Nevro: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [{"name": "nevro", "sentiment": "none"}], "locations": [{"name": "redwood city", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "redwood city", "sentiment": "none"}], "organizations": [{"name": "nevro corp.", "sentiment": "negative"}, {"name": "nvro", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "REDWOOD CITY, Calif. (AP) _ Nevro Corp. (NVRO) on Monday reported a loss of $17.7 million in its first quarter.\nOn a per-share basis, the Redwood City, California-based company said it had a loss of 59 cents.\nThe results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.\nThe maker of an electrical implant that treats leg and back pain posted revenue of $87.6 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $88.6 million.\nNevro expects full-year revenue in the range of $400 million to $410 million.\nNevro shares have increased 33 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $92.03, a climb of slightly more than 1 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on NVRO at https://www.zacks.com/ap/NVRO", "external_links": ["https://www.zacks.com/ap/NVRO", "http://automatedinsights.com/ap"], "published": "2018-05-08T00:39:00.000+03:00", "crawled": "2018-05-08T02:22:30.020+03:00", "highlightTitle": ""}